ProQR Therapeutics develops RNA therapies to potentially transform the lives of patients suffering from inherited retinal diseases. 

Biotechnology

ProQR Therapeutics

ProQR Therapeutics' headquarters in Leiden, Netherlands

Daniel A. de Boer

Gerard Platenburg

Guus Hateboer

Robin Besuyen

Dennis Hom

Vincent Adiceam

Alise Vilumsone

Bart Klein

Jurriaan Dekkers

Sheila Sponselee

Peter Beal

Martin Maier

Yi-Tao Yu

Bart Filius

James Shannon

John Maraganore

Begoña Carreño

Theresa Heggie

Dinko Valerio

Alison Lawton

This department conducts studies and analysis to generate insights and advance knowledge in specific fields.

Research Department

This department focuses on scientific research and innovation to develop new products and technologies.

Research and Development

This department focuses on conducting advanced research and development in scientific disciplines.

Scientific Research

The Finance and Accounting team at ProQR Therapeutics manages financial operations, ensures regulatory compliance, and supports strategic decision-making. They oversee budgeting, financial reporting, internal controls, and audits, playing a critical role in sustaining the company's mission to develop RNA therapies for inherited retinal diseases.

Finance and Accounting

This department oversees research program direction and intellectual property strategies.

Research Management

This department focuses on providing expert guidance and support in scientific matters, ensuring adherence to industry standards and advancing research initiatives.

ProQR Therapeutics

Org chart

Board & advisors

Teams

Research Department

Research and Development

Scientific Research

Finance and Accounting

Research Management

Scientific Affairs

Offices

ProQR Therapeutics

Org chart

Board & advisors

Teams

Research Department

Research and Development

Scientific Research

Finance and Accounting

Research Management

Scientific Affairs

Offices

Related companies